دورية أكاديمية

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

التفاصيل البيبلوغرافية
العنوان: FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.
المؤلفون: Paschali, Anna N., Gnanasegaran, Gopinath, Cook, Gary J.
المصدر: Indian Journal of Nuclear Medicine; Apr-Jun2017, Vol. 32 Issue 2, p122-124, 3p
مصطلحات موضوعية: BLEOMYCIN, VIGILANCE (Psychology), ONCOLOGY, RADIOLOGISTS, POSITRON emission tomography, THERAPEUTICS
مستخلص: Bleomycin-induced interstitial lung disease is not a rare complication of treatment and may prove to be fatal if not suspected early in its course. As FDG PET-CT has become an essential clinical tool for interim and end-of-treatment response assessment in oncology, it is important that radiologists/nuclear medicine specialists be aware of the features of this potentially treatable condition so that treatment can be instigated during an early reversible phase before pulmonary damage has occurred. Herein, we report two cases of bleomycin toxicity featuring different patterns on the treatmentresponse assessment FDG PET-CT scan. [ABSTRACT FROM AUTHOR]
Copyright of Indian Journal of Nuclear Medicine is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09723919
DOI:10.4103/0972-3919.202242